Latvian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Journal of Rheumatology 2000-Jun

Development and testing of a systemic lupus-specific risk adjustment index for in-hospital mortality.

Rakstu tulkošanu var veikt tikai reģistrēti lietotāji
Ielogoties Reģistrēties
Saite tiek saglabāta starpliktuvē
M M Ward

Atslēgvārdi

Abstrakts

OBJECTIVE

Valid comparison of patient outcomes among hospitals requires adjustment for differences in the severity of patients' illness. Disease-specific indexes of severity of illness may permit more accurate risk adjustment than generic indexes. The objective of this study was to develop a systemic lupus-specific risk adjustment index for in-hospital mortality, and to compare its performance to that of the generic Charlson index.

METHODS

A systemic lupus-specific risk adjustment index was developed using discharge abstract data from a 50% random sample (n = 4994) of patients with systemic lupus erythematosus (SLE) hospitalized on an emergent or urgent basis in California from 1991 to 1994 (n = 9989). The index was tested on the remaining members of the sample. Candidate variables for the index were the diagnoses included in the original Charlson index, and nephritis, chronic renal failure, pericarditis, pleuritis, psychosis, seizures, hemolytic anemia, and thrombocytopenia. Multivariate logistic regression analysis was used to identify the set of variables that best differentiated those patients who died in the hospital from those who survived, and to provide the weights for construction of the index.

RESULTS

In the derivation set of patients, the SLE-specific index accurately predicted in-hospital mortality (area under the receiver operating characteristic curve c = 0.79). In the test set, the SLE-specific index (c = 0.72) was similar to the original Charlson index (c = 0.74) in its ability to predict in-hospital mortality (p = 0.32). However, the SLE-specific index accounted for substantially more variation in the risk of mortality among patients (R2 = 0.069) than did the Charlson index (R2 = 0.036). Use of the SLE-specific index rather than the Charlson index for risk adjustment did not alter the association between hospital experience and the probability of in-hospital mortality. Results were similar in the subgroups of patients with emergent hospitalizations and those with emergent hospitalizations due to SLE.

CONCLUSIONS

The SLE-specific risk adjustment index developed from diagnoses recorded in administrative discharge abstracts performed similarly to the generic Charlson index in correctly classifying mortality outcomes, but the SLE-specific index stratified patients by their level of risk of mortality better than the Charlson index. Adjustment for SLE-specific risks of mortality did not alter the association between hospital experience and the risk of in-hospital mortality.

Pievienojieties mūsu
facebook lapai

Vispilnīgākā ārstniecības augu datu bāze, kuru atbalsta zinātne

  • Darbojas 55 valodās
  • Zāļu ārstniecības līdzekļi, kurus atbalsta zinātne
  • Garšaugu atpazīšana pēc attēla
  • Interaktīva GPS karte - atzīmējiet garšaugus atrašanās vietā (drīzumā)
  • Lasiet zinātniskās publikācijas, kas saistītas ar jūsu meklēšanu
  • Meklēt ārstniecības augus pēc to iedarbības
  • Organizējiet savas intereses un sekojiet līdzi jaunumiem, klīniskajiem izmēģinājumiem un patentiem

Ierakstiet simptomu vai slimību un izlasiet par garšaugiem, kas varētu palīdzēt, ierakstiet zāli un redziet slimības un simptomus, pret kuriem tā tiek lietota.
* Visa informācija ir balstīta uz publicētiem zinātniskiem pētījumiem

Google Play badgeApp Store badge